Metformin Maximum Tolerated Dose | Sulfonamides | Basal insulin
Item
patients treated for at least 3 months with metformin (at the maximum tolerated dose (for at least 1 month) + / - sulfamide and basal insulin
boolean
C0025598 (UMLS CUI [1,1])
C0752079 (UMLS CUI [1,2])
C0038760 (UMLS CUI [2])
C0650607 (UMLS CUI [3])
Hemoglobin A1c measurement
Item
patient with an hba1c between 7 and 9% at the inclusion visit
boolean
C0474680 (UMLS CUI [1])
Use of Glucose measurement by monitoring device
Item
patients able to use a continuous glucose monitoring system,
boolean
C1524063 (UMLS CUI [1,1])
C0202048 (UMLS CUI [1,2])
Therapeutic procedure Postprandial | Glucagon-Like Peptide 1
Item
patients already receiving a specific treatment of postprandial (glp1, ..)
boolean
C0087111 (UMLS CUI [1,1])
C0376674 (UMLS CUI [1,2])
C0061355 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent | Secondary diabetes mellitus
Item
patients with type 1 diabetes, or secondary diabetes
boolean
C0011854 (UMLS CUI [1])
C0271640 (UMLS CUI [2])
Eating Disorders
Item
patients with eating disorders
boolean
C0013473 (UMLS CUI [1])
Complications of Diabetes Mellitus Major
Item
patients with major complications of diabetes
boolean
C0342257 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
Study Subject Participation Status
Item
patients participating in another clinical trial
boolean
C2348568 (UMLS CUI [1])
Pregnancy
Item
pregnant
boolean
C0032961 (UMLS CUI [1])